An abundant dysfunctional apolipoprotein A1 in human atheroma. - Wikidata - awgldk - TriplyDB

An abundant dysfunctional apolipoprotein A1 in human atheroma.

An abundant dysfunctional apolipoprotein A1 in human atheroma.

http://www.wikidata.org/entity/Q37581580

about

Structural Insights into High Density Lipoprotein: Old Models and New Facts HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications The role of the lymphatic system in cholesterol transport Protein carbamylation and cardiovascular disease Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?AIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and Atherosclerosis Cholesterol, inflammation and innate immunity HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.Rational drug design applied to myeloperoxidase inhibition.Tyrosine-Nitrated Proteins: Proteomic and Bioanalytical Aspects.Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal Antibodies High-density lipoprotein metabolism, composition, function, and deficiency.Apolipoprotein A-I mimetics.Association of cholesteryl ester transfer protein (CETP) gene polymorphism, high density lipoprotein cholesterol and risk of coronary artery disease: a meta-analysis using a Mendelian randomization approach HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function Plant-based, no-added-fat or American Heart Association diets: impact on cardiovascular risk in obese children with hypercholesterolemia and their parents.Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill Patients Reconstituted high-density lipoproteins promote wound repair and blood flow recovery in response to ischemia in aged mice.Plasma Nitration of High-Density and Low-Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants.Inference and quantification of peptidoforms in large sample cohorts by SWATH-MS.Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction Serum apolipoprotein A-1 quantification by LC-MS with a SILAC internal standard reveals reduced levels in smokers.Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications.Polyphenol rich olive oils improve lipoprotein particle atherogenic ratios and subclasses profile: A randomized, crossover, controlled trial iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis.Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo Protein Oxidation in the Lungs of C57BL/6J Mice Following X-Irradiation.Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease.High-density lipoprotein, beta cells, and diabetes .High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.

P2860

Q26770434-7AD794AF-D2CD-4612-8BB2-A17C41F0F502 Q26779667-3CE09880-93CF-4FFA-A9DB-B82BA460B66C Q26782973-60E0B67A-BD4C-481F-9002-B784F68D4D4A Q26827410-BCCCEF7D-BDD7-461A-B381-5D15E9958C07 Q27325561-FCE7905B-BF24-4036-BB6A-757F53EB4FA9 Q28080768-CE33957C-2E7D-47D0-8B79-14BCE73C0D5F Q28083058-4657361E-90D3-4208-9440-874AA5F2310C Q28086912-0FFBAC08-CADF-45AE-BB29-679B56B9A268 Q30251918-0764AD1E-52FE-49A1-A146-F2D71DDB157E Q30372838-2412C839-0C05-4B33-92EA-B90EC4823058 Q30389594-3F3511F0-99E5-44E5-AB8C-B605FC535439 Q33675617-76801EA3-48E8-4D97-BE25-2DF1F9C38161 Q33704372-075827FB-A6B8-4B88-ABD7-F14D0872576A Q33774419-85E83A5D-60E8-4664-A882-1E3227182699 Q33848028-31FE99FE-B404-4ACB-BF40-D39F6EFC99D8 Q34421191-09B5AC72-6EA1-4BFC-978D-D0E21AAB31D4 Q34649579-35ADEC65-35F4-4F5B-9CEF-C446BAB74E92 Q35120941-F9BCD19E-DC69-42EA-B9B4-D681FA2793BA Q35236328-E2159EDE-465C-4968-A540-79F30C4D51FD Q35536293-A6FD50C6-26F6-4450-9AF4-CBF31DD4F627 Q35618507-4CD40492-5654-45DC-A55B-1C63E4D6EBEB Q35886286-0C81B824-38B2-445F-A3CF-9B405C6BFD3C Q35957788-3946292B-9801-4F6B-A367-41F2F9845C32 Q36124505-890D506A-CDF5-485F-A9AF-C8DE36497D1B Q36327959-060239B3-3AD0-4E9C-9035-2737A9F09C8D Q36399003-5E40A86E-8232-4B56-B9BC-EE1519A798C4 Q36489313-2AAE08DA-97FA-491E-A406-B9D2FD0D5F04 Q36533665-663C713A-2656-4BC2-A978-358F4F8BFE57 Q36604395-B09806E4-72B9-4D7E-973C-8D0EF7333944 Q36744820-0249C1E9-25FE-4D7E-8B66-CD2FCFB70784 Q36796655-86DA6DB3-5BEE-4297-84DF-42355EB31B37 Q37104660-8E75E2E7-DE75-42B9-9B56-2E8D7F3794F2 Q37236242-0C47185E-CBF3-42D7-9577-FEDF5240724D Q37270341-CB5E3B63-3A71-4510-A5FD-770F8BAF540D Q37566453-AE8D4C0E-30B4-4F3F-A96E-B29ACC511B6C Q37576165-A6ED054E-C81F-484F-8735-EFDE70F3B3EA Q37673515-0D210DD2-E3B6-4003-A94D-729A92A41790 Q37707747-11FF922F-F8ED-4BF0-8690-B9064559CA53 Q38218039-25B810DC-87C5-4772-9126-13D628CB5579 Q38220761-D12D210A-DA14-4CB3-9BF0-24F517EDCA97

P2860

An abundant dysfunctional apolipoprotein A1 in human atheroma.

http://www.wikidata.org/entity/Q37581580

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

An abundant dysfunctional apolipoprotein A1 in human atheroma.

@en

An abundant dysfunctional apolipoprotein A1 in human atheroma.

@nl

type

label

An abundant dysfunctional apolipoprotein A1 in human atheroma.

@en

An abundant dysfunctional apolipoprotein A1 in human atheroma.

@nl

prefLabel

An abundant dysfunctional apolipoprotein A1 in human atheroma.

@en

An abundant dysfunctional apolipoprotein A1 in human atheroma.

@nl

P1433

Q37581580-07C8D519-EB0D-4931-B4FF-35D0D9847919

P1476

Q37581580-1F256088-840E-49CA-B22D-15E2893F529A

P2093

Q37581580-065E0727-9867-4473-9790-4DE4535887FA

Q37581580-10BB66A7-7E84-4FF5-8079-8DF578239F3C

Q37581580-11AECC02-5C0B-435F-A8A4-DFC4C7AA8167

Q37581580-14F4C464-138E-4E57-B3C3-061D999A9DAA

Q37581580-16E8AAB6-470D-4FD5-AF69-5F791B4783FB

Q37581580-29C7B6CE-66C9-4421-8BF7-13432581325B

Q37581580-53AC7474-42E3-49C9-A114-066F3D35CB61

Q37581580-540936AF-4D61-4A7E-9651-0D29155FF617

Q37581580-592920A3-3CA5-4D96-9BE6-3D7EE5283D83

Q37581580-6CBDEB49-4710-4871-ABDC-7FFE7E6E0C06

P2860

Q37581580-019F7508-319D-470B-9A52-19B2CD7B7EB1

Q37581580-0406E5E4-B72C-4A29-9493-E070A9A687C5

Q37581580-05843D4C-032B-4546-A56F-AE3E4761A011

Q37581580-0B71D5AA-9E64-4B0F-9209-E123089235AC

Q37581580-0B96E8E7-9545-4205-A17D-32AD3618C8B7

Q37581580-15B83D52-BAE0-4F3F-A171-29DDB417C794

Q37581580-15E7816F-4D73-48D2-893C-853CE70757AD

Q37581580-1866EE9A-C780-4D99-A685-E09D87A71A00

Q37581580-1B1BBAB2-D34F-4368-9D5F-61FBDA2D7B50

Q37581580-1D087DA1-CA96-4687-8B80-3E7D35C746B7

P2888

Q37581580-A9CB53B6-BBCA-4290-B5F6-78375C67FAD4

P304

Q37581580-7FB18284-7B05-4F45-ACC3-2462532E9F8F

P31

Q37581580-591BA1E3-02D7-4A86-A140-8C81BF5F8987

P356

Q37581580-C2176A1B-B6F2-4B48-83E3-5FDA2C3F9C9F

P407

Q37581580-FEAAF26F-6F9E-4923-B6FE-A7EBEFB85D9A

P433

Q37581580-C7374324-CD12-4F9A-BDD6-771EF5AADEBF

P478

Q37581580-14FF1E3D-B66A-4986-BAC4-E197559857EC

P50

Q37581580-1301847E-D2B3-4E76-8EE2-A94A2FFF953F

Q37581580-229711C4-80B0-42E8-9BA2-88CE6DF1F546

Q37581580-38CE5A5B-9C7E-4428-BCE6-8A417F37B7A5

Q37581580-55DDABB9-2C1D-4526-A6EC-8CFF4361D740

P577

Q37581580-EE80EC87-AFD0-4200-BC42-F27400616AC7

P5875

Q37581580-93F50228-055A-4323-A249-855758A391DD

P698

Q37581580-2395E5A2-841C-47A5-AEC7-A44BBA8E92EE

P932

Q37581580-05B48170-EEEE-4481-AA99-82E12E96E7CC

P356

P1433

Nature Medicine

P1476

An abundant dysfunctional apolipoprotein A1 in human atheroma.

@en

P2093

Anthony J Didonato

http://www.w3.org/2001/XMLSchema#string

Chandra S Kadiyala

http://www.w3.org/2001/XMLSchema#string

Chia-Chi Chuang

http://www.w3.org/2001/XMLSchema#string

Daoquan Peng

http://www.w3.org/2001/XMLSchema#string

Dave Schmitt

http://www.w3.org/2001/XMLSchema#string

Edward F Plow

http://www.w3.org/2001/XMLSchema#string

Gary S Gerstenecker

http://www.w3.org/2001/XMLSchema#string

Jennie E Hazen

http://www.w3.org/2001/XMLSchema#string

Jennifer Buffa

http://www.w3.org/2001/XMLSchema#string

John S Parks

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous cultures of fused cells secreting antibody of predefined specificity

Double Superhelix Model of High Density Lipoprotein

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Effect of torcetrapib on the progression of coronary atherosclerosis

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration

The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects

HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis

Nitric oxide is a physiological substrate for mammalian peroxidases

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

P2888

P304

193-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.3459

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Edward A Fisher

Bruce S. Levison

Jonathan D Smith

P577

2014-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259918766

http://www.w3.org/2001/XMLSchema#string

P698

24464187

http://www.w3.org/2001/XMLSchema#string

P932

3923163

http://www.w3.org/2001/XMLSchema#string